Remote Opioid Use Disorder Research Study

Researchers at the Medical University of South Carolina (MUSC) are conducting a study on improving sleep for individuals receiving medication-assisted treatment for opioid use disorder.

Fast Facts

Initiated or Modified Dose of Buprenorphine (Suboxone or Subutex) Treatment in The Last 3 Months

Experience Poor Sleep Quality

Compensation

Provided

Conducted Remotely Nationwide

Study Background

Poor sleep is common among individuals receiving treatment for opioid use disorder, but there are few effective, accessible solutions.

This study aims to develop and test a mobile health (mHealth) behavioral sleep intervention app designed specifically for people receiving medications such as buprenorphine. The app uses evidence-based strategies from behavioral sleep medicine to help participants track and improve their sleep patterns.

By engaging with the app over several weeks, participants will contribute valuable feedback that will help researchers refine and evaluate the program’s effectiveness in improving sleep health and supporting recovery.

Study Background

Poor sleep is common among individuals receiving treatment for opioid use disorder, but there are few effective, accessible solutions.

This study aims to develop and test a mobile health (mHealth) behavioral sleep intervention app designed specifically for people receiving medications such as buprenorphine. The app uses evidence-based strategies from behavioral sleep medicine to help participants track and improve their sleep patterns.

By engaging with the app over several weeks, participants will contribute valuable feedback that will help researchers refine and evaluate the program’s effectiveness in improving sleep health and supporting recovery.

Additional Information

This study is being conducted to test whether a smartphone-based behavioral sleep program can help individuals receiving medication-assisted treatment improve their sleep quality.

You may be eligible for this study if you meet the following criteria.

Inclusion Criteria:

  • Initiated or modified dose of buprenorphine (suboxone or subutex) treatment in the last 3 months
  • Experience poor sleep quality
  • Diagnosed with opioid use disorder
  • Ages 18+
  • Able to read and understand English
  • Own an Android or iOS smartphone
  • If female, not pregnant

Exclusion Criteria:

  • Experiencing psychotic symptoms

If eligible, you will:

  • Complete a consent appointment and an interview about your sleep and mental health

  • Use the study app for 6 weeks to complete daily sleep activities and logs

  • Attend a follow-up appointment after app use

Participants can receive up to $200 for completing all parts of the study.

There is no cost for you to participate in our research study.